Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elif Hilal Vural"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objectives: Cancer diagnosis is increasing day by day all over the world. Deaths due to cancer are among the most common causes of death. Access to cancer drugs is a priority of health policies. The aim of this study is to evaluate access to cancer d
Externí odkaz:
https://doaj.org/article/c9e603675d7e49dab29f309714812e0d
Autor:
Elif Hilal Vural, Esra Şafak Yılmaz, Güven Bektemür, İsmail Mert Vural, Banu Bayar, Hakkı Gürsöz
Publikováno v:
Haseki Tıp Bülteni, Vol 57, Iss 2, Pp 108-113 (2019)
Aim:The top 100 medicines having the highest annual average sales between the years 2006 and 2015, had exceeded one-fourth of the total pharmaceutical market’s value in these years. We aimed to study the status of biotechnological medicines among t
Externí odkaz:
https://doaj.org/article/7ffd4499e68c46bfa1e5ca67fbb798c5
Autor:
Guven Bektemur, Esra Safak Yilmaz, Elif Hilal Vural, Enver Kagan Atikeler, Banu Bayar, Hakki Gursoz
Publikováno v:
Medicine Science, Vol 7, Iss 3, Pp 684-90 (2018)
There have been many developments that affected the Turkish pharmaceutical market following the Health Transformation Program (2003) and Social Security Reform (2006). The objective of this study was to investigate effects of the developments in Turk
Externí odkaz:
https://doaj.org/article/fd40e6bc05db419da63f5f37ca024177
Introduction and utilisation of high priced HCV medicines across Europe; implications for the future
Autor:
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most patients. Sales of medicines to treat HCV infection grew 2.7% per year between 20
Externí odkaz:
https://doaj.org/article/442ad35f14564b47bc0809c09511b491
Publikováno v:
Haseki Tıp Bülteni, Vol 57, Iss 2, Pp 108-113 (2019)
Aim:The top 100 medicines having the highest annual average sales between the years 2006 and 2015, had exceeded one-fourth of the total pharmaceutical market’s value in these years. We aimed to study the status of biotechnological medicines among t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b876163a47af90c207af9599843e35
https://doi.org/10.4274/haseki.galenos.2018.4566
https://doi.org/10.4274/haseki.galenos.2018.4566
Autor:
BEKTEMÜR, GÜVEN, Karabekmez, nurgül, Yılmaz, Esra şafak, MALHAN, BERNA SİMTEN, Atikeler, Enver Kağan, Gürsöz, Hakkı, beyan, aslıhan, Doğan, engin, Elif Hilal, Vural, babacan, salih, Tolun, Çiğdem, OĞUZÜLGEN, İPEK KIVILCIM, vural, ismail mert, kahveci, Rabia, Eroğlu, Hakan, Kutkan, Nurcan Uman, alkan, Ali, ALTIN, SEDAT, bayar, banu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10046::8fd6ba651cd55dd98b77cf2895a3e7b0
https://avesis.gazi.edu.tr/publication/details/607dae48-dba8-47fb-b782-22364a41be65/oai
https://avesis.gazi.edu.tr/publication/details/607dae48-dba8-47fb-b782-22364a41be65/oai
Autor:
Enver Kagan Atikeler, Simten Malhan, Hakkı Gürsöz, Elif Hilal Vural, Engin Doğan, Nurgül Karabekmez, Çiğdem Tolun, Hakan Eroğlu, Banu Bayar, Güven Bektemür, I.M. Vural, Salih Babacan, Aslıhan Beyan, Ali Alkan, Rabia Kahveci, Ipek Kivilcim Oguzulgen, Sedat Altın, Esra Safak Yilmaz, Nurcan Uman Kutkan
Publikováno v:
Value in health regional issues. 13
Background With the rise in life expectancy, the burden of chronic diseases, including obstructive pulmonary diseases, has increased throughout the world. Objectives To evaluate the sales trends of inhaler pharmaceuticals. Methods The changes in box
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c4b45ec502386344211ed611b544e8
https://pubmed.ncbi.nlm.nih.gov/29073985
https://pubmed.ncbi.nlm.nih.gov/29073985
Autor:
Güvenç Koçkaya, Elif Hilal Vural, Halil Akar, I. Mert Vural, Mahmut Tokaç, Salih Babacan, Pelin Tanyeri, Saim Kerman, Guven Artiran, Akif Akbulat
Publikováno v:
Journal of Pharmaceutical Health Services Research. 3:129-134
Objective In Turkey, compassionate use (CU) programmes were started in 2006. Patients suffering from a serious or urgent life-threatening disease, who have not responded to currently licensed and available medicinal products, who have not been enroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8128b7cac96fcb05835938b4aab30e8
https://doi.org/10.1111/j.1759-8893.2012.00090.x
https://doi.org/10.1111/j.1759-8893.2012.00090.x
Autor:
Rickard E. Malmström, Hanne Bak Pedersen, Marija Kalaba, Anna Bucsics, Kristina Garuoliene, Laura McCullagh, Ali Alkan, Vera Vlahović-Palčevski, Elif Hilal Vural, Azuwana Supian, Kaisa Miikkulainen, Stephen Campbell, Einar Magnisson, Eduardo Diogene, Sisira Jayathissa, Faridah Yusof, Alexander E. Finlayson, Augusto Afonso Guerra Junior, Susan Spillane, Wenjie Zeng, Irene Eriksson, Low Ee Vien, Gabriela Ofierska-Sujkowska, Winnie de Bruyn, Angela Timoney, Anna Brzezinska, Lars L. Gustafsson, Janet Wale, Catherine Sermet, Gisbert Selke, Jurij Fürst, Saira Jan, Jadwiga Czeczot, Andy Gray, Roberta Joppi, Francisco de Assis Acurcio, Jolanta Gulbinovič, Brian Godman, Magdalene Wladysiuk, Ilse Truter
Publikováno v:
Expert review of clinical pharmacology. 8(1)
Medicines have made an appreciable contribution to improving health. However, even high-income countries are struggling to fund new premium- priced medicines. This will grow necessitating the development of new models to optimize their use. The objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148287e03c07bbe158f8a550d7095527
https://pubmed.ncbi.nlm.nih.gov/25487078
https://pubmed.ncbi.nlm.nih.gov/25487078
Autor:
Esra Safak Yilmaz, Mert Vural, Hakan Türkçapar, Hakkı Gürsöz, Hasan Karadag, Saim Kerman, Ozgur Oner, Akif Akbulat, Elif Hilal Vural
Publikováno v:
Journal of attention disorders. 21(14)
Objective: To investigate the change of ADHD medication prescriptions in Turkey between 2009 and 2013. Method: Consumption data of ADHD medications, immediate release (IR) methylphenidate (MPH; Ritalin), OROS MPH (Concerta), and atomoxetine (Stratter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3079cf18290e00b48b1e80cba8f1d1
https://pubmed.ncbi.nlm.nih.gov/24554298
https://pubmed.ncbi.nlm.nih.gov/24554298